Clinical Trial

The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE

Study acronym: The REsOLVE Tr
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
An evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-01-01 -> 2028-09-01 2026-07-08
minor Completion pushed: 2028-01-01 -> 2028-12-01 2026-07-08
Trial Details
NCT Number NCT07450911
Lead Sponsor ReValve Solutions Inc.
Conditions Mitral Regurgitation
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29